Stockscreener 앱 받기
6.49
6.39%
0.39
시간 외 거래:
6.50
0.010
+0.15%
Nyxoah Sa 주식(NYXH)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
Nyxoah S.A. (NASDAQ:NYXH) Shares Bought by Geode Capital Management LLC - Defense World
LPL Financial LLC Buys Shares of 12,700 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
Press Release Distribution & PR Platform - ACCESS Newswire
Stifel cuts Nyxoah stock price target to $14, maintains Buy rating - Investing.com Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect - markets.businessinsider.com
Nyxoah Announces Conditional Issuance of 5 Million Shares - TipRanks
Nyxoah Expands ATM Program: 5.66M Total Shares Now Available for Market Sale - Stock Titan
Conditional Issuance of Shares - The Manila Times
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect - markets.businessinsider.com
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Nyxoah’s Final Hurdle for FDA Approval of Genio Neurostimulator for Sleep Apnea - sleepreviewmag.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation - ACCESS Newswire
Nyxoah Expects to Meet Final FDA Requirements for Sleep Apnea Treatment Device Approval in Q2 - MarketScreener
FDA Signals Green Light for Revolutionary Sleep Apnea TreatmentJust One Step Away - Stock Titan
Nyxoah Expects Q2 Approval of Genio System from US FDA - MarketScreener
Nyxoah Provides Update on FDA Approvable Letter for Genio System - The Manila Times
Nyxoah Provides Update On FDA Approvable Letter For Genio System - MarketScreener
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out - markets.businessinsider.com
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Invest - GuruFocus
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks By Investing.com - Investing.com South Africa
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com
Nyxoah S.A. Investors: Company Investigated By The Portnoy Law Firm - menafn
HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World
Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull
Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks
Nyxoah Says FDA Issues Approvable Letter for Genio System - MarketScreener
1.08%
자본화:
|
볼륨(24시간):